Publications

Filters: Biosimilar medicines
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Biosimilar Medicine Market Review 2020

29 March 2021

Report

Read More

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2021

Policy

Read More

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

10 February 2021

Report

Read More

Biosimilars in the EU – Information guide for healthcare professionals – unofficial Ukrainian translation now available

8 February 2021

External Resource

OPEN UNOFFICIAL UKRAINIAN TRANSLATION

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

Read More

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Factsheet

Read More

The total clinical experience with biosimilar medicines exceeds 2 billion patient treatment days

16 December 2020

Infographic

Read More

Biosimilar medicines are available in therapy areas which represent 65% of the biologics market by value

16 December 2020

Infographic

Read More

In Europe, biosimilar medicines have captured 7% more of the biologics market over a 5-year period

16 December 2020

Infographic

Read More

Growing number of biologic therapies offers future opportunities for biosimilar development

16 December 2020

Infographic

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]
Medicines For Europe